EP 2426142 A3 20120613 - Modified vaccinia virus strains for use in a diagnostic and therapeutic method
Title (en)
Modified vaccinia virus strains for use in a diagnostic and therapeutic method
Title (de)
Modifizierte Impfstoffvirusstämme zur Verwendung in einem Diagnose- und Therapieverfahren
Title (fr)
Souches de virus de vaccin modifiées pour une utilisation pour le diagnostic et procédé thérapeutique
Publication
Application
Priority
- EP 07872632 A 20071016
- US 85239006 P 20061016
- US 93305007 P 20070604
- US 95058707 P 20070718
- US 99479407 P 20070921
Abstract (en)
[origin: WO2008100292A2] Modified or attenuated viruses and methods for preparing the modified viruses and modulating attenuation are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including as anti-tumor agents. The viruses also can be used in diagnostic methods.
IPC 8 full level
A61K 33/241 (2019.01); A61K 33/242 (2019.01); A61K 33/243 (2019.01); A61K 33/244 (2019.01); A61K 35/76 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); C07K 14/54 (2006.01); C07K 14/715 (2006.01); C12N 7/04 (2006.01); C12N 15/863 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 31/282 (2013.01 - EP US); A61K 31/4745 (2013.01 - EP US); A61K 31/7068 (2013.01 - EP US); A61K 33/241 (2018.12 - EP US); A61K 33/242 (2018.12 - EP US); A61K 33/243 (2018.12 - EP US); A61K 33/244 (2018.12 - EP US); A61K 35/76 (2013.01 - US); A61K 38/1709 (2013.01 - EP US); A61K 38/1793 (2013.01 - EP US); A61K 38/20 (2013.01 - EP US); A61K 38/204 (2013.01 - EP US); A61K 38/36 (2013.01 - EP US); A61K 38/484 (2013.01 - EP US); A61K 39/12 (2013.01 - EP US); A61K 39/285 (2013.01 - EP US); A61K 39/3955 (2013.01 - US); A61K 45/06 (2013.01 - EP US); A61K 48/0058 (2013.01 - EP US); A61K 49/0008 (2013.01 - EP US); A61K 49/0045 (2013.01 - EP US); A61K 49/0047 (2013.01 - EP US); A61K 49/0097 (2013.01 - EP US); A61K 49/14 (2013.01 - EP US); A61K 49/1896 (2013.01 - EP US); A61K 51/00 (2013.01 - EP US); A61P 31/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); C07K 14/005 (2013.01 - EP US); C07K 14/47 (2013.01 - US); C07K 14/54 (2013.01 - EP US); C07K 14/5412 (2013.01 - US); C07K 14/7155 (2013.01 - US); C07K 16/22 (2013.01 - EP US); C12N 7/00 (2013.01 - EP US); C12N 15/86 (2013.01 - EP US); C12Q 1/04 (2013.01 - EP US); G01N 33/574 (2013.01 - EP US); G01N 33/585 (2013.01 - EP US); A61K 48/00 (2013.01 - EP US); A61K 2039/523 (2013.01 - EP US); A61K 2039/5254 (2013.01 - EP US); A61K 2039/5256 (2013.01 - EP US); C07K 2317/622 (2013.01 - EP US); C07K 2317/73 (2013.01 - EP US); C07K 2319/00 (2013.01 - US); C07K 2319/20 (2013.01 - EP US); C07K 2319/60 (2013.01 - EP US); C07K 2319/61 (2013.01 - EP US); C07K 2319/74 (2013.01 - US); C12N 2710/14171 (2013.01 - US); C12N 2710/24121 (2013.01 - US); C12N 2710/24122 (2013.01 - EP US); C12N 2710/24132 (2013.01 - EP US); C12N 2710/24141 (2013.01 - US); C12N 2710/24143 (2013.01 - EP US); C12N 2710/24162 (2013.01 - EP US)
Citation (search report)
- [YD] US 2005031643 A1 20050210 - SZALAY ALADAR A [US], et al
- [A] FR 2710536 A1 19950407 - TRANSGENE SA [FR]
- [X] SHIDA H ET AL: "EFFECTS AND VIRULENCES OF RECOMBINANT VACCINIA VIRUSES DERIVED FROMATTENUATED STRAINS THAT EXPRESS THE HUMAN T-CELL LEUKEMIA VIRUS TYPE I EVELOPE GENE", INTERVIROLOGY, KARGER, XX, vol. 62, no. 12, 1 December 1988 (1988-12-01), pages 4474 - 4480, XP001056061, ISSN: 0300-5526
- [YD] OZBEK S ET AL: "The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells", ONCOGENE, NATURE PUBLISHING GROUP, GB, vol. 20, no. 8, 22 February 2001 (2001-02-22), pages 972 - 979, XP002300404, ISSN: 0950-9232, DOI: 10.1038/SJ.ONC.1204180
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008100292 A2 20080821; WO 2008100292 A3 20090514; WO 2008100292 A8 20081127; EP 2097517 A2 20090909; EP 2097517 B1 20140604; EP 2415783 A1 20120208; EP 2415783 B1 20161214; EP 2426142 A2 20120307; EP 2426142 A3 20120613; US 10584317 B2 20200310; US 2009053244 A1 20090226; US 2009098529 A1 20090416; US 2009155287 A1 20090618; US 2011293527 A1 20111201; US 2013273007 A1 20131017; US 2015175976 A1 20150625; US 2018195050 A1 20180712; US 8052968 B2 20111108; US 8066984 B2 20111129; US 9005602 B2 20150414; US 9944903 B2 20180417
DOCDB simple family (application)
US 2007022172 W 20071016; EP 07872632 A 20071016; EP 11183721 A 20071016; EP 11183725 A 20071016; US 201113136519 A 20110802; US 201313986866 A 20130612; US 201514638604 A 20150304; US 201815910525 A 20180302; US 8076608 A 20080404; US 97508807 A 20071016; US 97509007 A 20071016